Stockscreener 앱 받기
25.24
0.08%
-0.02
시간 외 거래:
25.24
전일 마감가:
$25.26
열려 있는:
$25.24
하루 거래량:
4,029
Relative Volume:
0.46
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.24%
1개월 성능:
-0.63%
6개월 성능:
+0.12%
1년 성능:
+0.00%
1일 변동 폭
$25.24
$25.25
1주일 범위
$25.24
$25.33
52주 변동 폭
$24.96
$25.54
Shl Telemedicine Ltd Performanc Stock (STBF) Company Profile
STBF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STBF
Shl Telemedicine Ltd Performanc
|
25.24 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
274.97 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
558.80 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
561.54 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
219.18 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
481.41 | 124.43B | 0 | 0 | 0 | 0.00 |
Shl Telemedicine Ltd Performanc 주식(STBF)의 최신 뉴스
Take Care Before Jumping Onto SHL Telemedicine Ltd. (VTX:SHLTN) Even Though It's 26% Cheaper - Simply Wall St
DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care - Business Wire
SHL Telemedicine (NASDAQ:SHLT) Shares Up 23.7%What's Next? - MarketBeat
Y.D. More Investments Ltd Reduces Stake in SHL Telemedicine Ltd - GuruFocus.com
SHL Telemedicine stock hits 52-week low at $2.54 amid challenges By Investing.com - Investing.com South Africa
SHL Telemedicine stock hits 52-week low at $2.54 amid challenges - Investing.com
Shareholders in SHL Telemedicine (VTX:SHLTN) have lost 83%, as stock drops 11% this past week - Simply Wall St
SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine - Business Wire
SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity - Business Wire
SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test - Business Wire
SHL Telemedicine Announces Official Launch of SmartHeart - Business Wire
SHL Announces Full-Year 2023 ResultsStable Revenue Growth Alongside Groundbreaking Clinical Milestones - Business Wire
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care - Business Wire
SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment - Business Wire
SHL Telemedicine Receives Buy Rating with $11.00 Price Target - Business Wire
SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US - Business Wire
SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits - Business Wire
SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US - Business Wire
SHL Announces Half-Year Results 2023 – Strategic Moves to Accelerate Growth - Business Wire
SHL Telemedicine to Commence Trading on NASDAQ Under the Symbol "SHLT" - PR Newswire
Shl Telemedicine Ltd Performanc (STBF) 재무 분석
Shl Telemedicine Ltd Performanc (STBF)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.67%
자본화:
|
볼륨(24시간):